AADR vs CGSLX

AADR is an ETF, whereas CGSLX is a mutual fund. Below is the comparison between AADR and CGSLX.

AADR CGSLX
Security Type ETF Mutual fund
Segment Equity: Global Ex-U.S. - Total Market Growth Specialty: Health
Family AdvisorShares N/A
Net Assets $43.70M N/A
Expense Ratio 1.10% N/A
Management Style passive (index-based) active
Dividend Yield 0.31% N/A
Minimum Investment N/A $1,000,000.00
YTD Return -23.35% N/A
1-Year Return -24.53% N/A
3-Year Return -1.29% N/A
5-Year Return 3.90% N/A
10-Year Return 6.44% N/A

AADR

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return -23.35%
1-Month Return -0.50%
3-Month Return -12.96%
1-Year Return -24.53%
3-Year Return -1.29%
5-Year Return 3.90%
10-Year Return 6.44%
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (38.80% of Total Assets)

Name Symbol % Assets
ASML Holding NV ADR ASML 5.52%
BioNTech SE ADR BNTX.DE 4.57%
Danaos Corp DAC.AX 4.48%
LVMH Moet Hennessy Louis Vuitton SE ADR LVMUY.PA 4.16%
Himax Technologies Inc ADR HIMX 3.79%
Sibanye Stillwater Ltd ADR SBSW.JO 3.64%
Logitech International SA LOGN 3.51%
Cemex SAB de CV ADR CX.MX 3.22%
Embraer SA ADR ERJ.SA 3.06%
POSCO ADR PKX.KS 2.85%

AADR pros

None that we could think of.

AADR cons

None that we could think of.

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

    Or use Finny's Comparison Tool to create a comparison you'd like to see.

    CGSLX

    CGSLX description

    null

    CGSLX performance & returns

    YTD Return N/A
    1-Month Return N/A
    3-Month Return N/A
    1-Year Return N/A
    3-Year Return N/A
    5-Year Return N/A
    10-Year Return N/A
    CGSLX expense ratio is N/A.

    CGSLX holdings

    Top 10 Holdings (52.27% of Total Assets)

    Name Symbol % Assets
    Merck & Co Inc MRK 7.53%
    UnitedHealth Group Inc UNH 6.97%
    Celgene Corp CELG 6.28%
    Roche Holding AG Dividend Right Cert. RHHVF 5.70%
    Allergan PLC AGN 4.98%
    Biogen Inc BIIB 4.82%
    Aetna Inc AET 4.39%
    Amgen Inc AMGN 4.36%
    Thermo Fisher Scientific Inc TMO 3.67%
    Alexion Pharmaceuticals Inc ALXN 3.57%

    CGSLX pros

    The following are CGSLX strengths from our perspective:

    • Good news: this fund does not have 12b1, front-end or back-end sales fees.

    CGSLX cons

    The following are CGSLX weaknesses from our perspective:

    • CGSLX net assets are $0.00 million. This fund is not a popular choice with retail investors.

    Other relevant CGSLX comparisons

    You may also want to check out the following CGSLX comparisons that investors often look for on Finny

    Or use Finny's Comparison Tool to create a comparison you'd like to see.
    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.